Sun-Woo Hong
Vorstandsvorsitzender bei mCureX Therapeutics, Inc.
Vermögen: 706 890 $ am 30.04.2024
Profil
Sun-Woo Hong is currently the Chief Executive Officer at mCureX Therapeutics, Inc. Prior to this, he worked as the Director, Senior Managing Director & Head-Research at OliX Pharmaceuticals, Inc. Dr. Hong completed his undergraduate and doctorate degrees from Pohang University of Science & Technology and his graduate degree from Korea University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.03.2024 | 62 348 ( 0,38% ) | 706 890 $ | 30.04.2024 |
Aktive Positionen von Sun-Woo Hong
| Unternehmen | Position | Beginn |
|---|---|---|
mCureX Therapeutics, Inc.
 mCureX Therapeutics, Inc. BiotechnologyHealth Technology mCureX Therapeutics, Inc. is a South Korean company that specializes in drug development. The private company is based in Seongnam-si, South Korea. The company is known for being the first mover in the mRNA drug development market. It was founded in 2021 and the CEO is Sun-Woo Hong. | Vorstandsvorsitzender | 01.01.2021 |
Ehemalige bekannte Positionen von Sun-Woo Hong
| Unternehmen | Position | Ende |
|---|---|---|
| OLIX PHARMACEUTICALS, INC | Direktor/Vorstandsmitglied | - |
Ausbildung von Sun-Woo Hong
| Pohang University of Science & Technology | Doctorate Degree |
| Korea University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OLIX PHARMACEUTICALS, INC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
mCureX Therapeutics, Inc.
mCureX Therapeutics, Inc. BiotechnologyHealth Technology mCureX Therapeutics, Inc. is a South Korean company that specializes in drug development. The private company is based in Seongnam-si, South Korea. The company is known for being the first mover in the mRNA drug development market. It was founded in 2021 and the CEO is Sun-Woo Hong. | Health Technology |
